hotspot -WSS

hotspot

author：explore 2025-09-28 23:24:26 - browse：5714

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

WSS

AMAs digital advisors table RPM coding reform proposal, again

Resistance to opioid

Travis Kelce and the trap of celebrity vaccine endorsements

Bill would allow buprenorphine prescription for addiction via telehealth

Artificial intelligence use in health care faces greater scrutiny in 2024

Artificial intelligence use in health care faces greater scrutiny in 2024

knowledge

hotspot

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Resistance to opioid

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How to convince healthy people to buy insurance

Drug repurposing or repositioning? The language matters

AMAs digital advisors table RPM coding reform proposal, again

Trump demands the U.S. pay no more for drugs than other countries … again

Readout LOUD podcast: ESMO highlights & Roivant's big deal

BioMarin wins approval for gene therapy to treat hemophilia A

Humans aren't the only ones with an imagination. Rats have it too

focus

Juul documents reveal insider tactics on political lobbying

Kidney transplant patients stopped immunosuppressants in trial

Medicare proceeds with plan to claw back hospital funds

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Ebola vaccine can save some who are already sick, per new study

entertainment

focus

focus

hotspot